Stock Scorecard



Stock Summary for Veru Inc (VERU) - $2.29 as of 4/2/2026 9:48:19 PM EST

Total Score

12 out of 30

Safety Score

27 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for VERU

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VERU

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VERU

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for VERU

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for VERU (27 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 6
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 2
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for VERU

Veru SEC Filings 4/2/2026 10:09:00 AM
Veru Inc. (VERU) Stock Price Quote Today & Current Price Chart 3/31/2026 5:10:00 AM
Veru Q1 2026 earnings preview 3/31/2026 12:08:00 AM
Veru outlines Phase III plans for enobosarm and signals upcoming FDA clarity on lean mass preservation in obesity treatment 3/25/2026 8:09:00 PM
If You Invested $1,000 in Veru (VERU) 3/22/2026 2:09:00 PM
Veru Shareholders Expand Equity Plan, Reelect Board Leadership 3/16/2026 1:40:00 PM
Veru Inc. Amends 2018 Equity Incentive Plan and Reports Annual Meeting Results – Form 8-K Filing March 12, 2026 3/14/2026 7:51:00 AM
Veru (NASDAQ: VERU) investors back larger equity plan, board slate and auditor 3/13/2026 7:51:00 PM
Veru Inc. (NASDAQ: VERU) Q1 2026 earnings call transcript 3/12/2026 2:52:00 PM
Veru enrolls first patient in obesity drug combination trial By Investing.com 3/10/2026 2:52:00 AM

Financial Details for VERU

Company Overview

Ticker VERU
Company Name Veru Inc
Country USA
Description Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 12/31/2025
Next Earnings Date 5/14/2026

Stock Price History

Last Day Price 2.29
Price 4 Years Ago 52.80
Last Day Price Updated 4/2/2026 9:48:19 PM EST
Last Day Volume 32,101
Average Daily Volume 51,052
52-Week High 7.40
52-Week Low 2.06
Last Price to 52 Week Low 11.17%

Valuation Measures

Trailing PE N/A
Industry PE 28.01
Sector PE 53.11
5-Year Average PE -31.65
Free Cash Flow Ratio 1.11
Industry Free Cash Flow Ratio 13.11
Sector Free Cash Flow Ratio 28.27
Current Ratio Most Recent Quarter 5.16
Total Cash Per Share 2.06
Book Value Per Share Most Recent Quarter 2.31
Price to Book Ratio 0.99
Industry Price to Book Ratio 10.39
Sector Price to Book Ratio 21.37
Price to Sales Ratio Twelve Trailing Months 1.79
Industry Price to Sales Ratio Twelve Trailing Months 22.78
Sector Price to Sales Ratio Twelve Trailing Months 25.63
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 16,050,300
Market Capitalization 36,755,187
Institutional Ownership 24.24%

Dividends

Ex-Dividend Date 4/28/2014
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0700
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage -48.15%
3-Year Dividend Growth Rate Percentage -21.98%
5-Year Dividend Growth Rate Percentage -8.53%
All-Time Dividend Growth Rate Percentage -8.53%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 39.88%
Reported EPS 12 Trailing Months -1.21
Reported EPS Past Year -0.26
Reported EPS Prior Year -0.54
Net Income Twelve Trailing Months -19,113,511
Net Income Past Year -22,726,279
Net Income Prior Year -37,801,426
Quarterly Revenue Growth YOY 18.30%
5-Year Revenue Growth -100.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet

Total Cash Most Recent Quarter 32,991,417
Total Cash Past Year 15,794,562
Total Cash Prior Year 24,916,285
Net Cash Position Most Recent Quarter 24,140,625
Net Cash Position Past Year 6,943,770
Long Term Debt Past Year 8,850,792
Long Term Debt Prior Year 8,850,792
Total Debt Most Recent Quarter 8,850,792
Equity to Debt Ratio Past Year 0.67
Equity to Debt Ratio Most Recent Quarter 0.81
Total Stockholder Equity Past Year 18,332,670
Total Stockholder Equity Prior Year 32,316,712
Total Stockholder Equity Most Recent Quarter 37,124,041

Free Cash Flow

Free Cash Flow Twelve Trailing Months -24,879,595
Free Cash Flow Per Share Twelve Trailing Months -1.55
Free Cash Flow Past Year -30,044,171
Free Cash Flow Prior Year -21,840,655

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.05
MACD Signal -0.04
20-Day Bollinger Lower Band 2.10
20-Day Bollinger Middle Band 2.42
20-Day Bollinger Upper Band 2.75
Beta -1.45
RSI 37.91
50-Day SMA 3.81
150-Day SMA 6.99
200-Day SMA 26.48

System

Modified 4/2/2026 10:45:48 AM EST